United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis

United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis

The United States Proton Therapy Market is expected to reach US$ 1.8 Billion by 2027. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumours close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.

COVID-19 Impact on United States Proton Therapy Industry:

Despite the outbreak of COVID-19 worldwide, the proton therapy market has increased at a constant speed. It was only stopped for a brief period in the initial months of the pandemic outbreak but later resumed to take care of the cancer patients and radiation therapies patients in the United States; many procedures have been finalized to help the patients with therapies. Such as, many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.

United States Proton Therapy Market will grow with a CAGR of 8.5% during the period 2021-2027

The rise of the proton therapy industry in the United States is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access along with premium pricing. As per our analysis, United States Proton Therapy Market Size was US$ 1.1 Billion post-pandemic recoveries in 2021.

Cancer Types - Market Segmentation:

Based on Cancer Types, the proton therapy market of the United States is further segmented into Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, and Breast Cancer.

Besides, proton therapy applications are more inclined towards Gastrointestinal Tract Cancer and lung cancer due to references by healthcare specialists. Moreover, proton therapy is also recognized to be comparatively safer in the case of paediatric patients who have cancer. These applications are anticipated to drive the revenue for the proton therapy industry over the forecast period.

Competitive Landscape:

Companies in the United States Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich their product catalogues through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players of the United States Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.

Renub Research latest report “Proton Therapy Patients Number & Market, Global Forecast By Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer and Others), Company (IBA Proton Therapy, Varian Medical Systems, Elekta)” provides a detailed analysis of United States Proton Therapy Industry.

Cancer Types – United States Proton Therapy Market has been covered from 14 viewpoints:

1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer Cases (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. By Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

Cancer Types – Patients Number in United States Proton Therapy Market has been covered from 14 viewpoints:

1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

All companies have been covered from 3 viewpoints:

• Overview
• Recent Developments
• Sales Analysis

Companies Covered:

1. IBA Proton Therapy
2. Varian Medical Systems
3. Elekta